Two Sigma Securities, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.07 - $0.12 $1,942 - $3,330	-27,756 Reduced 46.8%	31,553 $2,000
Q2 2023 Aug 14, 2023	BUY	$0.08 - $0.29 $3,198 - $11,595	39,984 Added 206.9%	59,309 $5,000
Q1 2023 May 15, 2023	SELL	$0.24 - $0.34 $436 - $618	-1,820 Reduced 8.61%	19,325 $5,000
Q4 2022 Feb 14, 2023	BUY	$0.18 - $0.3 $3,806 - $6,343	21,145 New	21,145 $4,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $1.1 $8,511 - $14,861	13,510 New	13,510 $10,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.